Researcher
Ann Vankerckhoven
- Disciplines:Oncology, Immunology
Affiliations
- Laboratory for Tumor Immunology and Immunotherapy (Division)
Member
From2 Jul 2018 → 30 Sep 2022
Projects
1 - 1 of 1
- Unravelling The Tumour Immune-Biology Of Ovarian CancerFrom1 Oct 2018 → 24 Oct 2022Funding: Foundations, funds and other with scientific goal
Publications
1 - 10 of 11
- A Microfluidics Approach for Ovarian Cancer Immune Monitoring in an Outpatient Setting.(2024)
Authors: Ann Vankerckhoven, Thaïs Baert, Toon Van Gorp, An Coosemans, Liesbet Lagae
- Do autoimmune diseases influence the onset and progression of ovarian cancer? A systematic review and meta-analysis(2022)
Authors: Roxanne Wouters, Ann Vankerckhoven, Jolien Ceusters, An Coosemans
Pages: 1583 - 1591 - Unravelling The Tumour Immune-Biology Of Ovarian Cancer(2022)
Authors: Ann Vankerckhoven, An Coosemans, Stefaan Soenen
- Effect of Particle Carriers for Intraperitoneal Drug Delivery on the Course of Ovarian Cancer and Its Immune Microenvironment in a Mouse Model(2022)
Authors: Roxanne Wouters, Ann Vankerckhoven, Jolien Ceusters, Dominique Schols, Ignace Vergote, An Coosemans
- Neo-Adjuvant Chemotherapy Reduces, and Surgery Increases Immunosuppression in First-Line Treatment for Ovarian Cancer(2021)
Authors: Christine De Bruyn, Jolien Ceusters, Thaïs Baert, Ann Vankerckhoven, Roxanne Wouters, Dominique Schols, Dirk Timmerman, Ignace Vergote, An Coosemans
- Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer(2021)
Authors: Jenny Sprooten, Ann Vankerckhoven, Isaure Vanmeerbeek, Yani Berckmans, Roxanne Wouters, Thaïs Baert, Tom Bourne, Wouter Froyman, Dominique Schols, Patrizia Agostinis, et al.
- Type of chemotherapy has substantial effects on the immune system in ovarian cancer(2021)
Authors: Ann Vankerckhoven, Thaïs Baert, Matteo Riva, Christine De Bruyn, Jolien Ceusters, Ignace Vergote, An Coosemans
- Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot Study(2020)
Authors: Ann Vankerckhoven, Roxanne Wouters, Jolien Ceusters, Thaïs Baert, Holger Gerhardt, Ignace Vergote, An Coosemans
- Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer(2019)
Authors: Thaïs Baert, Ann Vankerckhoven, Matteo Riva, Ignace Vergote, An Coosemans
- Combining conventional therapy with immunotherapy: A risky business?(2019)
Authors: An Coosemans, Ann Vankerckhoven, Thaïs Baert, Matteo Riva, Michel Delforge, Ignace Vergote
Pages: 41 - 44